Cramer sees Anadarko Petroleum profiting and Coach returning to its former glory.
Worried about a bad event? There will be money coming off the sidelines afterward. Be prepared to buy on weakness.
FBR Capital analysts are remaining bullish on Seres Therapeutics (MCRB) despite the company's second quarter earnings miss.